デフォルト表紙
市場調査レポート
商品コード
1009705

高薬理活性原薬(HPAPI)の世界市場:製品別、メーカー別、薬剤タイプ別、治療アプリケーション別、地域別の、市場規模調査と予測(2021年~2027年)

Global High Potency Active Pharmaceutical Ingredients Market Size study, by Product, by Manufacturer, by Drug Type, Therapeutic Application and Regional Forecasts 2021-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.01円
高薬理活性原薬(HPAPI)の世界市場:製品別、メーカー別、薬剤タイプ別、治療アプリケーション別、地域別の、市場規模調査と予測(2021年~2027年)
出版日: 2021年06月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の高薬理活性原薬(HPAPI)の市場規模は2020年に約210億8,000万米ドルとなり、2021年~2027年の予測期間中に10.00%を超える健全な成長率で成長すると予想されています。

医薬品有効成分(API)は、医薬品の製造に使用される原材料または物質の混合物です。APIは、空気1立方メートルあたり10マイクログラム以下の職業暴露限界がある場合、高薬理活性原薬(HPAPI)として分類されます。それらは、他のAPIよりも正確かつ選択的に罹患細胞を標的とする能力を持っているため、癌などの疾患において非常に重要です。

癌患者の治療におけるHPAPIの需要の高まり、民間および政府関係者からの投資の増加、精密治療への注目の高まりがHPAPI市場の主な推進力です。上記の利点は、HPAPIの製造における新しい技術開発と相まって、HPAPI市場の成長を推進しています。APIは製薬業界の重要な部分です。

COVID-19パンデミック後の業界の著しく高い成長により、APIの需要が増加しました。パンデミックの封鎖中に医薬品のサプライチェーンに大きな混乱が生じ、その結果、世界中でAPIが不足しました。インドや他のアジア諸国を含むさまざまな政府は現在、中国への依存を減らすために国内でAPIの製造をアップグレードしようとしています。これらの努力はまた、高薬理活性原薬(HPAPI)市場の成長を推進しています。

2020年、インド政府はAPIの国内製造を促進するためのProduction Linked Incentive(PLI)スキームを発表しました。このスキームでは、今後6年間で53のAPIをカバーする既知の41の適格製品の適格メーカーに金銭的インセンティブが与えられます。政府の別のスキームでは、さまざまな州の3つのバルクドラッグパークに共通のインフラ施設を建設するための資金援助を提供するために3,000ルピークローレを割り当てています。

効力の高いAPIは本質的に毒性があるため、廃棄には高度な注意が必要です。APIに関連する管理、保管、および関連する規制の問題は、APIの成長を妨げる可能性があります。ただし、HPAPIを必要とする癌やその他の疾患の症例の増加は、この後の10年間でHPAPI市場の機会として機能します。

当レポートでは高薬理活性原薬(HPAPI)の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、製品・メーカー・薬剤タイプ・治療アプリケーション・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の定義と範囲

第3章 市場力学

  • 市場の影響分析(2019年~2027年)

第4章 業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 製品別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 合成
    • バイオテクノロジー

第6章 メーカー別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 社内
    • アウトソーシング

第7章 薬剤タイプ別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 革新的
    • ジェネリック

第8章 治療アプリケーション別

  • 市場のスナップショット
  • パフォーマンス:潜在的な分析
  • 市場規模予測:2018年~2027年(10億米ドル単位)
  • サブセグメント分析
    • 腫瘍学
    • ホルモン
    • 緑内障
    • その他

第9章 地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Eli Lilly and Company
    • Novartis AG
    • Bristol-Myers Squibb Company
    • Roche Diagnostics Ltd.
    • Sanofi
    • Hospira, Inc.
    • BASF SE
    • Covidien plc
    • Boehringer Ingelheim GmbH
    • Merck & Co., Inc.

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global HPAPI Market, report scope
  • TABLE 2. Global HPAPI Market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global HPAPI Market estimates & forecasts by Product 2018-2027 (USD Billion)
  • TABLE 4. Global HPAPI Market estimates & forecasts by Manufacturer 2018-2027 (USD Billion)
  • TABLE 5. Global HPAPI Market estimates & forecasts by Drug Type 2018-2027 (USD Billion)
  • TABLE 6. Global HPAPI Market estimates & forecasts by Therapeutic 2018-2027 (USD Billion)
  • TABLE 7. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global HPAPI Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global HPAPI Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. U.S. HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. U.S. HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. Canada HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Canada HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. Canada HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. UK HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. UK HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. UK HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Germany HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Germany HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Germany HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. RoE HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. RoE HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. RoE HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. China HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. China HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. China HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. India HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. India HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. India HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Japan HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Japan HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Japan HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. RoAPAC HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Brazil HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. Brazil HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Brazil HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Mexico HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. Mexico HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. Mexico HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. RoLA HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. RoLA HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. RoLA HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Row HPAPI Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Row HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Row HPAPI Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global HPAPI Market
  • TABLE 57. List of primary sources, used in the study of global HPAPI Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global HPAPI Market, research methodology
  • FIG 2. Global HPAPI Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global HPAPI Market, key trends 2020
  • FIG 5. Global HPAPI Market, growth prospects 2021-2027
  • FIG 6. Global HPAPI Market, porters 5 force model
  • FIG 7. Global HPAPI Market, pest analysis
  • FIG 8. Global HPAPI Market, value chain analysis
  • FIG 9. Global HPAPI Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global HPAPI Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global HPAPI Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global HPAPI Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global HPAPI Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global HPAPI Market, regional snapshot 2018 & 2027
  • FIG 15. North America HPAPI Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe HPAPI Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific HPAPI Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America HPAPI Market 2018 & 2027 (USD Billion)
  • FIG 19. Global HPAPI Market, company market share analysis (2020)
目次

Global HPAPI Market is valued approximately USD 21.08 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.00% over the forecast period 2021-2027. Active pharmaceutical ingredient is a raw substance or mixture of substances used in the manufacturing of a medicinal drug. An API is classified as an HPAPI if it has an occupational exposure limit at or below 10 micrograms per cubic meter of air. They have the ability to target the diseased cells more precisely and selectively than other APIs and hence are very crucial in diseases such as cancer. The higher demand for HPAPIs in the treatment of cancer patients, increasing investments from private and government players and growing focus on precision treatment are the major drivers for HPAPI market. Above mentioned advantages, coupled with the new technological development in manufacturing of HPAPI, are propelling the growth of the HPAPI market. The APIs are the crucial part of pharmaceutical industry. The significantly high growth of the industry after the COVID-19 pandemic has increased the demand of APIs. There was a huge disruption in pharmaceutical supply chain during lockdowns in pandemic which resulted in scarcity of APIs worldwide. The various governments, including Indian and other Asian countries, are now trying to upgrade the manufacturing of APIs domestically to reduce the reliance on China. These efforts are also driving the growth of high potency active pharmaceutical ingredients market. In 2020, the government of India announced Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of APIS, in which financial incentive will be given to qualified manufacturers of known 41 eligible products which covers 53 APIs for next 6 years. Another scheme from government allocates INR 3000 Crores for providing financial assistance for construction of common infrastructure facilities in 3 bulk drug parks across various states. High potency APIs are toxic in nature and thus require high level of care in their disposal. The issue in the management, storage and associated regulations with APIs may act as a restraint for its growth. However, increasing cases of cancer and other diseases requiring HPAPIs act as an opportunity for HPAPI Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of HPAPI Market. Due to higher demand in oncology treatment as well as higher per capita income, North America emerged as a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing number of cancer patients and increasing expenditure on healthcare facilities.

Major market player included in this report are:

Eli Lilly and Company

Novartis AG

Bristol-Myers Squibb Company

Roche Diagnostics Ltd.

Sanofi

Hospira, Inc.

BASF SE

Covidien plc

Boehringer Ingelheim GmbH

Merck & Co., Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Synthetic

Biotech

By Manufacturer:

In-house

Outsourced

By Drug-Type:

Innovative

Generic

By Therapeutic:

Oncology

Hormonal

Glaucoma

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global HPAPI Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1.Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. HPAPI Market, by Product, 2019-2027 (USD Billion)
    • 1.2.2. HPAPI Market, by Manufacturer, 2019-2027 (USD Billion)
    • 1.2.3. HPAPI Market, by Drug Type, 2019-2027 (USD Billion)
    • 1.2.4. HPAPI Market, by Therapeutic, 2019-2027 (USD Billion)
    • 1.2.5. HPAPI Market, by, 2019-2027 (USD Billion)
    • 1.2.6. HPAPI Market, by, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global HPAPI Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global HPAPI Market Dynamics

  • 3.1. HPAPI Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase demand from oncology patients
      • 3.1.1.2. Rise in R&D expenditure in high potency APIs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Handling and management of toxic HPAPIs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising cases of cancer-related diseases

Chapter 4. Global HPAPI Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global HPAPI Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global HPAPI Market by Product, Performance - Potential Analysis
  • 5.3. Global HPAPI Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
  • 5.4. HPAPI Market, Sub Segment Analysis
    • 5.4.1. Synthetic
    • 5.4.2. Biotech

Chapter 6. Global HPAPI Market, by Manufacturer

  • 6.1. Market Snapshot
  • 6.2. Global HPAPI Market by Manufacturer, Performance - Potential Analysis
  • 6.3. Global HPAPI Market Estimates & Forecasts by Manufacturer 2018-2027 (USD Billion)
  • 6.4. HPAPI Market, Sub Segment Analysis
    • 6.4.1. In-house
    • 6.4.2. Outsourced

Chapter 7. Global HPAPI Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global HPAPI Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global HPAPI Market Estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
  • 7.4. HPAPI Market, Sub Segment Analysis
    • 7.4.1. Innovative
    • 7.4.2. Generic

Chapter 8. Global HPAPI Market, by Therapeutic

  • 8.1. Market Snapshot
  • 8.2. Global HPAPI Market by Therapeutic, Performance - Potential Analysis
  • 8.3. Global HPAPI Market Estimates & Forecasts by Therapeutic 2018-2027 (USD Billion)
  • 8.4. HPAPI Market, Sub Segment Analysis
    • 8.4.1. Oncology
    • 8.4.2. Hormonal
    • 8.4.3. Glaucoma
    • 8.4.4. Others

Chapter 9. Global HPAPI Market, Regional Analysis

  • 9.1. HPAPI Market, Regional Market Snapshot
  • 9.2. North America HPAPI Market
    • 9.2.1. U.S. HPAPI Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Manufacturer breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. Drug Type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.4. Therapeutic breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada HPAPI Market
  • 9.3. Europe HPAPI Market Snapshot
    • 9.3.1. U.K. HPAPI Market
    • 9.3.2. Germany HPAPI Market
    • 9.3.3. France HPAPI Market
    • 9.3.4. Spain HPAPI Market
    • 9.3.5. Italy HPAPI Market
    • 9.3.6. Rest of Europe HPAPI Market
  • 9.4. Asia-Pacific HPAPI Market Snapshot
    • 9.4.1. China HPAPI Market
    • 9.4.2. India HPAPI Market
    • 9.4.3. Japan HPAPI Market
    • 9.4.4. Australia HPAPI Market
    • 9.4.5. South Korea HPAPI Market
    • 9.4.6. Rest of Asia Pacific HPAPI Market
  • 9.5. Latin America HPAPI Market Snapshot
    • 9.5.1. Brazil HPAPI Market
    • 9.5.2. Mexico HPAPI Market
  • 9.6. Rest of The World HPAPI Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Eli Lilly and Company
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Novartis AG
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. Roche Diagnostics Ltd.
    • 10.2.5. Sanofi
    • 10.2.6. Hospira, Inc.
    • 10.2.7. BASF SE
    • 10.2.8. Covidien plc
    • 10.2.9. Boehringer Ingelheim GmbH
    • 10.2.10. Merck & Co., Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption